Key statistics
On Friday, Rezolute Inc (RZLT:NAQ) closed at 4.91, -20.62% below its 52-week high of 6.19, set on Nov 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.78 |
---|---|
High | 4.99 |
Low | 4.68 |
Bid | 4.91 |
Offer | 5.10 |
Previous close | 4.86 |
Average volume | 406.13k |
---|---|
Shares outstanding | 57.94m |
Free float | 50.26m |
P/E (TTM) | -- |
Market cap | 281.60m USD |
EPS (TTM) | -1.27 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
More ▼
- Rezolute Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update
- Rezolute to Participate in Upcoming Investor Conferences
- Rezolute Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results and Provides Business Update
- FDA Lifts Partial Clinical Holds on RZ358 for the Treatment of Congenital Hyperinsulinism and Authorizes U.S. Inclusion in Ongoing Phase 3 Study
- Rezolute Announces FDA Clearance of IND Application for Phase 3 Registrational Study of RZ358 for Treatment of Hypoglycemia Due to Tumor Hyperinsulinism
- Rezolute to Participate in the BTIG Virtual Biotechnology Conference
- Rezolute Announces Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement
- Rezolute Announces Closing of Public Offering with Approximately $60M in Gross Proceeds
- Rezolute Announces Pricing of Public Offering of $60 Million of Common Stock and Pre-Funded Warrants
- Rezolute Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
More ▼